B
Biomea Fusion D
D
BMEA
3.46000
USD
-0.19
(-5.21%)
مغلق
حجم التداول
8,768
الربح لكل سهم
-3
العائد الربحي
-
P/E
-1
حجم السوق
125,385,857
المقالات
العنوان: Biomea Fusion
القطاع: Healthcare
الصناعة: Biotechnology
Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.